A Randomised Trial Investigating the Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder.

Trial Profile

A Randomised Trial Investigating the Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder.

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Agomelatine (Primary) ; Escitalopram (Primary)
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Sponsors Servier
  • Most Recent Events

    • 17 Dec 2013 Additional lead trial cente added as reported by ClinicalTrials.gov.
    • 17 Dec 2013 Planned initiation date changed from 1 Sep 2012 to 1 Jan 2014 as reported by ClinicalTrials.gov.
    • 14 Aug 2012 Planned initiation date changed from 1 Feb 2012 to 1 Sep 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top